This study found that mice with non-catalytic TET2 mainly developed myeloid malignancies, while mice with complete loss of TET2 developed both myeloid and lymphoid disorders, supporting the unique non-catalytic role of TET2 in the hematopoietic stem and progenitor cell homeostasis.188. Here, TET2 is linked to myeloid neoplasm.